← Back to Search

Smartphone App Monitoring for Blood Pressure Management

N/A

Recruiting

Led By Frederic Frappereau

Research Sponsored by Biospectal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be comfortable communicating in written and spoken English

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial tests how a phone app can help measure and monitor blood pressure, using AI technology.

Who is the study for?

This trial is for adults living in the USA who have an Android smartphone, access to a blood pressure cuff, and can download the OptiBP app. They must be comfortable with English and able to consent. Excluded are those with certain heart rhythm disorders or skin reactions to metals, or hand lesions.Check my eligibility

What is being tested?

The study is testing the OptiBP mobile app that uses machine learning to estimate blood pressure. Participants will use their own smartphones and arm-worn blood pressure monitors as part of data collection for app evaluation.See study design

What are the potential side effects?

Since this trial involves data collection using an app, there are no direct medical side effects expected from participating. However, participants should be aware of privacy considerations when sharing health data.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am comfortable with both speaking and writing in English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Collect Blood Pressure (BP) data and assess performance of smartphone based BP estimations models

Secondary outcome measures

Safety by assessing inconvenience and adverse events

Trial Design

1Treatment groups

Experimental Treatment

Group I: Principal ArmExperimental Treatment1 Intervention

Each participant will use the OptiBP Study app on their smartphone

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

BiospectalLead Sponsor

1 Previous Clinical Trials

350 Total Patients Enrolled

Frederic FrappereauPrincipal InvestigatorBiospectal

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being enrolled in this medical experiment?

"Affirmative. Clinicaltrials.gov's data reveals that this study is currently recruiting participants, with the initial posting on September 28th 2023 and most recent update also occurring on that day. The trial seeks to enrol 500000 patients at a single site."

Answered by AI

Is enrollment being accepted for this investigation?

"Indeed, the information available on clinicaltrials.gov signifies that this experiment is currently in need of participants. The trial was first announced on September 28th 2023 and has been updated since then; 500000 volunteers are called for across one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Data Collection and Evaluation of OptiBP Under Investigational Use

2023. "Data Collection and Evaluation of OptiBP Under Investigational Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06017687.